Emami Ltd
Emami Ltd Share Price Today: Live Updates & Key Insights
Get insights on Emami Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Emami Ltd Share Price Chart
Emami Ltd Fundamentals
Traded Volume: 2,96,257
Market Cap(Cr): 22,406
Avg Traded Price 515.54
1 Year return -19.04%
Upper Circuit 522.4
Lower Circuit 512
P/E TTM 30.00
P/B Ratio 17.00
Traded Value(Cr) 1520.69
EPS TTM 17.269
Book value 17.269
Dividend 2.00%
Emami Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Emami Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Emami Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -1.70%
1M -5.20%
3M -18.08%
1Y -19.04%
YTD -14.68%
Emami Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Emami Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 18.62L
Day Before Yesterday 5.41L
1W Avg 8.76L
1M Avg 4.87L
3M Avg 6.68L
Emami Ltd Technical Details
Emami Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 509
Support 2 506
Support 3 499
Pivot Point : 516
Resistance 1 520
Resistance 2 526
Resistance 3 530
Emami Ltd Corporate Actions
Emami Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Emami Ltd’s capital allocation strategies.
All
Ex-Date 14-Nov-2025 Type D Description 4.00/share@400.00% Record Date 14-Nov-2025 Ratio 400.00
Ex-Date 22-May-2025 Type D Description 2.00/share@200.00% Record Date 22-May-2025 Ratio 200.00
Ex-Date 04-Feb-2025 Type D Description 4.00/share@400.00% Record Date 04-Feb-2025 Ratio 400.00
Ex-Date 18-Nov-2024 Type D Description 4.00/share@400.00% Record Date 18-Nov-2024 Ratio 400.00
Ex-Date 16-Feb-2024 Type D Description 4.00/share@400.00% Record Date 19-Feb-2024 Ratio 400.00
Ex-Date 15-Nov-2023 Type D Description 4.00/share@400.00% Record Date 15-Nov-2023 Ratio 400.00
Ex-Date 12-Apr-2023 Type O Description /share@% Record Date - Ratio
Ex-Date 12-Apr-2023 Type O Description /share@% Record Date - Ratio
Ex-Date 13-Feb-2023 Type D Description 4.00/share@400.00% Record Date 13-Feb-2023 Ratio 400.00
Ex-Date 18-Nov-2022 Type D Description 4.00/share@400.00% Record Date 21-Nov-2022 Ratio 400.00
Ex-Date 10-Feb-2022 Type D Description 4.00/share@400.00% Record Date 11-Feb-2022 Ratio 400.00
Ex-Date 08-Nov-2021 Type D Description 4.00/share@400.00% Record Date 09-Nov-2021 Ratio 400.00
Ex-Date 04-Feb-2021 Type D Description 4.00/share@400.00% Record Date 05-Feb-2021 Ratio 400.00
Ex-Date 12-Nov-2020 Type D Description 4.00/share@400.00% Record Date 13-Nov-2020 Ratio 400.00
Ex-Date 26-Mar-2020 Type D Description 2.00/share@200.00% Record Date 27-Mar-2020 Ratio 200.00
Ex-Date 14-Nov-2019 Type D Description 2.00/share@200.00% Record Date 15-Nov-2019 Ratio 200.00
Ex-Date 31-Jul-2019 Type D Description 4.00/share@400.00% Record Date - Ratio 400.00
Ex-Date 21-Jun-2018 Type B Description share@1:1 Record Date 22-Jun-2018 Ratio 1:1
Ex-Date 21-Jun-2018 Type D Description 7.00/share@700.00% Record Date 22-Jun-2018 Ratio 700.00
Ex-Date 26-Jul-2017 Type D Description 5.25/share@525.00% Record Date - Ratio 525.00
Ex-Date 14-Mar-2017 Type D Description 1.75/share@175.00% Record Date 15-Mar-2017 Ratio 175.00
Ex-Date 26-Jul-2016 Type D Description 7.00/share@700.00% Record Date - Ratio 700.00
Ex-Date 28-Jul-2015 Type D Description 3.00/share@300.00% Record Date - Ratio 300.00
Ex-Date 01-Aug-2014 Type D Description 4.00/share@400.00% Record Date 22-Sep-2014 Ratio 400.00
Ex-Date 01-Aug-2014 Type D Description 4.00/share@400.00% Record Date - Ratio 400.00
Ex-Date 24-Jan-2014 Type D Description 3.00/share@300.00% Record Date 27-Jan-2014 Ratio 300.00
Ex-Date 26-Jun-2013 Type B Description share@1:2 Record Date 27-Jun-2013 Ratio 1:2
Ex-Date 26-Jun-2013 Type D Description 8.00/share@800.00% Record Date 27-Jun-2013 Ratio 800.00
Ex-Date 02-Aug-2012 Type D Description 4.00/share@400.00% Record Date - Ratio 400.00
Ex-Date 02-Aug-2012 Type D Description 4.00/share@400.00% Record Date - Ratio 400.00
Ex-Date 05-Aug-2011 Type D Description 3.50/share@350.00% Record Date - Ratio 350.00
Ex-Date 21-Jul-2010 Type S Description share@1:2.00 Record Date 23-Jul-2010 Ratio 1:2.00
Ex-Date 21-Jul-2010 Type D Description 3.00/share@300.00% Record Date - Ratio 300.00
Ex-Date 22-Dec-2009 Type D Description 4.50/share@225.00% Record Date - Ratio 225.00
Ex-Date 18-Aug-2008 Type D Description 4.50/share@225.00% Record Date - Ratio 225.00
Ex-Date 20-Sep-2007 Type D Description 1.00/share@50.00% Record Date - Ratio 50.00
Ex-Date 22-Mar-2007 Type D Description 2.00/share@100.00% Record Date 23-Mar-2007 Ratio 100.00
Ex-Date 22-Mar-2007 Type D Description 1.00/share@50.00% Record Date 23-Mar-2007 Ratio 50.00
Dividends
Announcement Date 14-Nov-2025 Ex Dividend Date 14-Nov-2025 Dividend(%) 400
Announcement Date 22-May-2025 Ex Dividend Date 22-May-2025 Dividend(%) 200
Announcement Date 04-Feb-2025 Ex Dividend Date 04-Feb-2025 Dividend(%) 400
Announcement Date 18-Nov-2024 Ex Dividend Date 18-Nov-2024 Dividend(%) 400
Announcement Date 16-Feb-2024 Ex Dividend Date 16-Feb-2024 Dividend(%) 400
Announcement Date 15-Nov-2023 Ex Dividend Date 15-Nov-2023 Dividend(%) 400
Announcement Date 13-Feb-2023 Ex Dividend Date 13-Feb-2023 Dividend(%) 400
Announcement Date 18-Nov-2022 Ex Dividend Date 18-Nov-2022 Dividend(%) 400
Announcement Date 10-Feb-2022 Ex Dividend Date 10-Feb-2022 Dividend(%) 400
Announcement Date 08-Nov-2021 Ex Dividend Date 08-Nov-2021 Dividend(%) 400
Announcement Date 04-Feb-2021 Ex Dividend Date 04-Feb-2021 Dividend(%) 400
Announcement Date 12-Nov-2020 Ex Dividend Date 12-Nov-2020 Dividend(%) 400
Announcement Date 26-Mar-2020 Ex Dividend Date 26-Mar-2020 Dividend(%) 200
Announcement Date 14-Nov-2019 Ex Dividend Date 14-Nov-2019 Dividend(%) 200
Announcement Date 31-Jul-2019 Ex Dividend Date 31-Jul-2019 Dividend(%) 400
Announcement Date 21-Jun-2018 Ex Dividend Date 21-Jun-2018 Dividend(%) 700
Announcement Date 26-Jul-2017 Ex Dividend Date 26-Jul-2017 Dividend(%) 525
Announcement Date 14-Mar-2017 Ex Dividend Date 14-Mar-2017 Dividend(%) 175
Announcement Date 26-Jul-2016 Ex Dividend Date 26-Jul-2016 Dividend(%) 700
Announcement Date 28-Jul-2015 Ex Dividend Date 28-Jul-2015 Dividend(%) 300
Announcement Date 01-Aug-2014 Ex Dividend Date 01-Aug-2014 Dividend(%) 400
Announcement Date 01-Aug-2014 Ex Dividend Date 01-Aug-2014 Dividend(%) 400
Announcement Date 24-Jan-2014 Ex Dividend Date 24-Jan-2014 Dividend(%) 300
Announcement Date 26-Jun-2013 Ex Dividend Date 26-Jun-2013 Dividend(%) 800
Announcement Date 02-Aug-2012 Ex Dividend Date 02-Aug-2012 Dividend(%) 400
Announcement Date 02-Aug-2012 Ex Dividend Date 02-Aug-2012 Dividend(%) 400
Announcement Date 05-Aug-2011 Ex Dividend Date 05-Aug-2011 Dividend(%) 350
Announcement Date 21-Jul-2010 Ex Dividend Date 21-Jul-2010 Dividend(%) 300
Announcement Date 22-Dec-2009 Ex Dividend Date 22-Dec-2009 Dividend(%) 225
Announcement Date 18-Aug-2008 Ex Dividend Date 18-Aug-2008 Dividend(%) 225
Announcement Date 20-Sep-2007 Ex Dividend Date 20-Sep-2007 Dividend(%) 50
Announcement Date 22-Mar-2007 Ex Dividend Date 22-Mar-2007 Dividend(%) 50
Announcement Date 22-Mar-2007 Ex Dividend Date 22-Mar-2007 Dividend(%) 100
Bonus
Record Date 22-Jun-2018 Ex-Bonus Date 21-Jun-2018 Ratio 1:1
Record Date 27-Jun-2013 Ex-Bonus Date 26-Jun-2013 Ratio 1:2
Splits
Record Date 23-Jul-2010 Split Date 21-Jul-2010 Face Value (Before/After) 2.00/1.00
Others
Ex-Rights Date 12-Apr-2023 Premium(Rs.) Ratio
Ex-Rights Date 12-Apr-2023 Premium(Rs.) Ratio
Emami Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Emami Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Emami Ltd's relative performance and valuation against major competitors.
Stock Name Colgate-Palmolive (India) Ltd ₹2180.60 (+0.04%) M. Cap (Cr) 593.09 1 Yr Return (%) -18.95% P/E (TTM) 44.73 PB Ratio 35.63
Stock Name Procter & Gamble Hygiene and Health Care Ltd ₹12850.00 (-1.37%) M. Cap (Cr) 417.12 1 Yr Return (%) -19.06% P/E (TTM) 50.46 PB Ratio 42.27
Stock Name Gillette India Ltd ₹8276.50 (-1.52%) M. Cap (Cr) 269.73 1 Yr Return (%) -9.78% P/E (TTM) 46.99 PB Ratio 24.42
Stock Name Emami Ltd ₹513.30 (-1.14%) M. Cap (Cr) 224.06 1 Yr Return (%) -19.04% P/E (TTM) 29.72 PB Ratio 8.52
Stock Name Jyothy Labs Ltd ₹309.80 (-0.11%) M. Cap (Cr) 113.76 1 Yr Return (%) -23.57% P/E (TTM) 32.60 PB Ratio 8.23
Stock Name Honasa Consumer Ltd ₹286.70 (-1.22%) M. Cap (Cr) 93.28 1 Yr Return (%) +20.61% P/E (TTM) 70.91 PB Ratio 8.29
Stock Name Cupid Ltd ₹337.03 (+2.28%) M. Cap (Cr) 90.48 1 Yr Return (%) +306.65% P/E (TTM) 146.68 PB Ratio 26.44
Emami Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Emami Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 863.57 Mar 2024 739.80 Mar 2023 730.96 Mar 2022 595.85 Mar 2021 878.40
PARTICULARS Investing Activities Mar 2025 -464.76 Mar 2024 -192.29 Mar 2023 -105.59 Mar 2022 -187.90 Mar 2021 -199.96
PARTICULARS Financing Activities Mar 2025 -367.88 Mar 2024 -546.12 Mar 2023 -612.17 Mar 2022 -398.06 Mar 2021 -678.77
PARTICULARS Net Cash Flow Mar 2025 30.93 Mar 2024 1.39 Mar 2023 13.20 Mar 2022 9.88 Mar 2021 -0.33
Emami Ltd Shareholding Pattern
This shows the ownership breakdown of Emami Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 54.84%
Public 9.22%
Other Institutions 2.03%
FII 10.93%
Mutual Funds 22.97%
About Emami Ltd
Emami Limited was incorporated on March 11, 1983 with the name 'AMP Udyog Viniyog Limited'. Initially, R S Agarwal and R S Goenka set up a cosmetic manufacturing unit at Kolkata in 1974 as 'Kemco Chemicals', a partnership Firm. The cosmetic products, as well as Ayurvedic medicines, manufactured by the unit were marketed under the brand name of Emami. In the year 1978, Himani Ltd, a sick unit, was taken over by the Group and the new management decided to produce different types of health care items and toiletries with Ayurvedic preparation.In the year 1994, Himani Limited was then merged with AMP Udyog Viniyog Limited and the name was changed to Himani Limited with effect from May 5, 1994. In the year 1995, Kemco Chemicals, the partnership firm was converted into a public limited company under the name and style of Emami Limited with effect from April 1, 1995. In the year 1998, Emami Limited was then merged with Himani Limited and the name was changed to Emami Limited with effect from September 1, 1998.Emami Limited is one of India's leading FMCG companies engaged in manufacturing & marketing of personal care & healthcare products. Emami is the flagship company of the diversified Emami Group. The company sells over 300 diverse products. Emami's portfolio includes brands like Navratna, BoroPlus, Fair & Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, & Mentho Plus Balm, Dermicool and others.The company's product categories consists hair care, skin creams, soaps and lotions, talcum powder and ayurvedic healthcare products. Their product portfolio includes Navratna Oil, Boroplus Antiseptic Cream, Fair and Handsome, Navratna Cool Talc, Sona Chandi Chyawanprash, Zandu Balm, Himani Fast Relief, Emami Healthy & Fair, Emami Malai Kesar Cold Cream, Lalima, Sardi Ja and Zandu Pancharishta. Emami products are available in over 9.4 lac retail outlets across India through its network of 3,150 distributors and its global footprint spans over 60 countries including GCC, Europe, Africa, CIS countries & the SAARC. Emami has 8 manufacturing units across India. The company has ultra modern manufacturing facilities at Kolkata (West Bengal), Guwahati (Assam), Pantnagar (Uttarakhand), Vapi (Gujarat), Silvassa (Dadra & Nagar Haveli) and Talasari (Maharashtra). They have adopted the Total Quality Management system and all their manufacturing facilities have received cGMP and ISO 9001:2000 certifications. The company has 1 overseas unit in Bangladesh.In the year 2000, the company's investment undertaking was de-merged into Pan Emami Cosmed Ltd with a view to concentrate on their core FMCG business. In the year 2003, the company set up a new unit at Amingaon, Guwahati. Also, they obtained the certificate of Good Manufacturing Practices for its Pondicherry Units. During the year 2005-06, the company started a third party manufacturing unit in Baddi in Himachal Pradesh. They set up a wholly owned subsidiary company, namely Emami International FZE, in UAE, to expand their foreign market. In response to the marketplace reality, the company launched 'Navratna' cool talc, an extension of its hugely popular 'cool' oil brandDuring the year 2006-07, the company launched Fair and Handsome Fairness Cream for men, Fair & Ageless Fairness Cream, Boroplus Antiseptic Light Cream and Body Lotion and Mr. Black and Mrs. Black, herbal Hair Dye Powder and Malai Kesar Cold Cream in the personal care segment. Also, they launched Sona Chandi Healthy and Fair Baby Massage Oil, Good Morning, an Ayurvedic laxative Churna, Sardi Ja, a cough syrup and Vaporub and Memo-plus, a memory booster, Sanjeevan Dhara - a digestive in the market.During the year, as per the scheme of amalgamation, JB Marketing & Finance Ltd, the erstwhile marketing company of the Emami Group was amalgamated with the company. The equity shares of the company were listed on the National Stock Exchange Ltd. In May 2007, the company formed a wholly owned subsidiary company namely, Emami Realty Pvt Ltd. The company ventured into the realty business through this wholly owned subsidiary company.In November 2008, the company acquired 68.9% stake in Zandu Pharmaceutical Works Ltd at a consideration of Rs 713 crore and de-merged Zandu's FMCG business into the company. Simultaneously, real estate undertaking of the company comprising of their interest into Emami Realty Ltd and Zandu's non-core business comprising real estate was de-merged into Emami Infrastructure Ltd with effect from November 05, 2008.During the year 2009-10, the company launched new products namely, Boroplus Winter Lotion and Emami Malai Kesar Soap in the market. Also, they launched new product variants, Navratna Oil. They introduced Zandu Balm in a new bicolour plastic container. They opened a new depot in Coimbatore to widen South India sales. Also, they commenced operations in Bangladesh.In 2010, the company's net sales crossed of Rs 1000 crore milestone. During the year, the company carried out a stock split from Rs 2 to Re 1 per share.During 2011-12, the company increased its direct rural reach. The direct retail coverage increased to 5 lac outlets. During the year, the company initiated Bangladesh and Egypt units which are expected to become operational in 2012-13. During the year, the company upgraded the ayurvedic manufacturing facility at the BT Road unit as per WHO guidelines. The company also completed capacity expansion at its Pantnagar unit. During the year, the company completed integration of the southern distribution channel of Zandu with Emami. The company also enhanced focus on the marketing activities of healthcare products of Zandu.During 2012-13, the company fortified its direct rural reach across 600,000 outlets. During the year, the company's Bangladesh unit became operational. In 2013, the company launched BoroPlus Face wash. During 2013-14, the company expanded capacity at its Pantnagar and Amingaon facilities. The Vapi plant was revamped to match the WHO-GMP standards. During the year, the company increased direct retail presence among 625,000 retailers. During the year, both the Research & Innovation (R&I) centres at Kolkata and Mumbai facility became fully operational. On the overseas front, Emami started manufacturing oil at its Bangladesh plant during the year.In 2014, the company entered the male deodorants space with its brand HE. It also launched Fair & Handsome- Instant Fairness Face wash. Also during the year, the company acquired She Comfort brand of sanitary napkin from Mumbai-based Royal Hygiene Care, marking its foray into the feminine hygiene space.During 2014-15, Emami undertook capacity expansion initiatives across various units for various products. The company augmented Navratna Oil, BoroPlus Lotion and Vasocare Petroleum Jelly capacities at its Abhoypur plant and enhanced Pancharishtha capacity by 17% at its Vapi unit. During the year, the company started manufacturing Navratna Oil at its Dongari manufacturing plant to cater to export requirements. During the year, Emami initiated setting up a new manufacturing unit under the North-East mega project scheme which is expected to commence operations in FY 2016. The company launched 4 new products during the year. During the year, Emami acquired Fravin Pty Ltd, an Australian organic personal care product major with proven expertise in the realm of R&D, to gain a strong foothold in the highly regulated Australian market.In June 2015, the company acquired Ayurvedic Hair & scalp business of Kesh King at Rs 1684 crore (including duties & taxes). It also acquired controlling stake in Fravin Pty Ltd. During 2015-16, Emami invested Rs 150 crore to build a new plant in Assam, which is expected to commence operations by FY 2017. The planned total outlay for the unit is Rs 300 crore. During the year, the company increased direct retail reach to more than 6.4 lac outlets and direct coverage to 13,300 villages with a population less than 50,000.On 25 January 2016, Zandu Ayurveda, from the house of Emami Limited, announced the launch of Zandu Pure Honey without added sugar in the Indian market.On 8 August 2016, Emami announced the reintroduction of its pain solution balm Zandu Balm with a new and advanced formulation offering a more effective and faster pain solution.Emami's 3rd manufacturing unit at Pacharia, Assam was formally inaugurated on 14 November 2017. Located at Pacharia in the Kamrup district of Assam and spread over 34 acres of land, the new plant of the company is the largest production facility of Emami in India. This new facility of Emami Limited is a world-class facility which is designed to spread over a total planned floor area of over 50,000 sq.mt for a total production capacity of 90,000 MTPA. Raw material for the plant will be sourced both from indigenous and overseas locations as per the requirement. Total investment incurred for the new facility is over Rs 300 crore.On 7 December 2017, Emami announced a strategic investment in Helios Lifestyle Pvt Ltd (Helios) with an acquisition of 30% equity stake for an undisclosed consideration. Helios owns the fast-growing male grooming brand The Man Company. The equity stake will be acquired by 31 December 2018 through infusion of required funds in Helios. The Man Company(TMC) offers a head-to-toe range of premium men's grooming products in Bath & Body, Beard management, Shaving & Perfumes category. The products are currently sold online majorly through the company's own website - www.themancompany.com. All the products are based on premium essential oils and are free of harmful chemicals. The acquisition of stake by Emami is significant as it marks the company's entry in the fast growing online male grooming segment.On 5 February 2018, Emami Limited announced that it has entered into an agreement for strategic investment in Brillare Science Pvt Ltd (Brillare) through compulsory convertible preference shares (CCPS), which on conversion will result in 26% equity stake in Brillare basis the achievement of agreed future performance of the company. Brillare owns the premium hair & skin care portfolio for use in professional salons. Brillare also provides customised beauty treatment which enables salon professionals to treat multiple hair & skin concerns simultaneously.During the year 2018-19, the Company acquired a leading personal care products, Creme 21, a German brand. It launched personal and healthcare products like Fair and Handsome 5-in-1 Pimple Clear Instant Fairness Facewash, HE Magic Duo Deodorant, StrivedaLactation Supplement and Zandu Diabrishta - 21. It also launched variants of HE Deodorants (HE Intense Body Spray), Diamond ShineHair Colour (burgundy) and Navratna Smart Cool (Dynamite & Force). It launched the `Rahat Raja' television commercial to present Navratna as an antidote beyond the usual to sleeplessness, body ache and the premature greying of hair. It launched HE Magic Duo with a packaging innovation, combining two different fragrances in one bottle. It relaunched Fair & Handsome in innovative packaging. It launched Kesh King Oil with a differentiated special comb applicator to drive equity and consumer convenience. During year 2019-20, it relaunched key brands like Navratna Cool Talc, Zandu Pancharishta and BoroPlus lotions. It extended Emami's international presence to nearly 60 countries. It integrated the acquired Creme 21 brand into Emami's distribution network. It had 10 subsidiaries as of 31st March, 2020.During the year 2019-20, Company launched an extension 'Navratna' brand with Navratna Garam Oil to target lapsers in winters, offering solutions for headache, numbness and lethargy. It launched innovative products like Zandu Ayurvedic Cough Syrup, HE Magic Duo and Zandu Anand Balm in the domestic business. For the International markets, it launched new variants of Emami 7 Oils in Oneand a Perfect Derma Range under the BoroPlus brand.In 2020-21, Emami launched BoroPlus Organic Aloe Vera Gel, BoroPlus Hygiene range, EMASOL Home Hygiene range and various healthcare products under Zandu, which mitigates seasonal impact. It localised the supply chain in Bangladesh and contract manufacturing in Germany, Sri Lanka and Dubai, launched the entire range of oils in Bangladesh including Navratna Oil, 7 Oils in One and Kesh King, introduced Creme 21 in Bangladesh, launched health, hygiene and immunity boosting products, introduced localised herbal products while enhancing ayurveda globalisation, in regions like MENA, Bangladesh, Russia, Nepal. The Company introduced more than 50 new products and variants, majorly in the health and hygiene categories during the year. BoroPlus, with its nation-wide strong brand equity for its antiseptic and germ protection properties introduced a personal hygiene range consisting of Hand Sanitizer, Antiseptic Soap, Antiseptic Handwash, Hygiene Liquid and Body wash which received a very encouraging market response. Under the Zandu Healthcare range, the Company introduced Zandu Ayurvedic Sanitizer, Zandu Ortho Vedic Pain relief oil, ZanduAyush Kwath Powder, Zandu Single herbs range, Zandu Immu Soft Chews, Zandu Health Juices, Zandu Tulsi and Haldi Drops, among others. It launched a new brand EMASOL which offers a complete range of home hygiene products, with the unique proposition of 24 hr protection. It launched Immune India offer to make Zandu Immunity boosters affordable for Indians and help them boost their immunity. The Company had 8 subsidiaries as of 31 March, 2021.In March 2022, the Company acquired ``Dermicool, one of the leading brands in Prickly Heat and Cool Talc Segment from Reckitt Benckiser Healthcare India Pvt. Ltd. costing Rs 432 crore. It acquired a 20.65% equity stake in Tru Native F&B Pvt. Ltd., that markets nutrition products. It increased stake in the associate Company, Helios Lifestyle Pvt. Ltd from 33.09% to 49.53%.In year 2021-22, Brillare Science Private Limited became a subsidiary of the Company w.e.f. 1st October, 2021.During 2022-23, Helios Lifestyle Private Limited became a subsidiary of Emami Limited w.e.f 1st July, 2022. Emami International Personal Care Trading LLCUAE, wholly owned subsidiary of the Company incorporated on January 28, 2022 was made the Wholly Owned Subsidiary of Emami international FZE w.e.f. February 15, 2022.In 2024, Company entered the juice category through a strategic investment in Axiom Ayurveda Pvt Ltd, acquiring a 26% equity stake. It increased the stake in Brillare Science from 82.92% to 100%. It increased the distribution through Project Khoj resulted in an additional coverage of more than 20,000 towns in rural regions since the launch of the project. A cell-based model was developed for assessing wound healing efficacy, optimizing costs, and enabling effective claims for products. For haemorrhoids (piles), Zandu Pileave ointments andtablets were developed as a comprehensive therapy tool for Ayurvedic practitioners. The Company launched more than 35 new products and variants during the year in the Domestic business, primarily as digital-first launches on its D2C portal, Zanducare. Overall, the Company has introduced more than 90 new product developments on Zanducare since its inception, showcasing a commitment to diversification and innovation.The Company acquired the balance 70% stake in Helios Lifestyle Pvt Ltd, making it a wholly owned subsidiary in FY 2025. It launched over 25 new products in the domestic business, including 11 on its Direct-toConsumer (D2C) platform, Zanducare in 2025.
Chairman Emeritus
R S Agarwal
Registered office Emami Tower 687 Anandapur, E M Bypass, Kolkata, West Bengal, 700107
FAX :91-33-66136264
Background
Incorporation Year 1983
Face Value ₹1.00
Market Lot 1
FAQs on Emami Ltd
How to buy Emami Ltd shares on NSE?
To buy Emami Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Emami Ltd share price today?
The Emami Ltd share price on NSE is ₹513.30 today.
What is the market cap of Emami Ltd on NSE?
The company has a market capitalization of ₹22405.55.
What is the PE & PB ratio of Emami Ltd?
PE is 30 and PB is 17.
What is the 52 Week High and Low of Emami Ltd shares?
Emami Ltd stock price high: ₹743 Emami Ltd stock price low: ₹498.45.
How can I sell Emami shares?
In case you wish to sell Emami shares, you can sign up with a broker like Motilal Oswal. This is a one-stop investment platform where you can gain access to the stock exchanges once you open demat and trading accounts.
What is the ROI of Emami shares?
As on 7th April, The ROI of Emami shares over a 3-year period is 71.36%.
Can I buy Emami shares now?
You can buy shares at any time based on your own needs and financial objectives. All you need to do is to find a good brokerage platform like Motilal Oswal, open a demat account, open a trading account, and then get access to the stock exchange to buy shares.
How has the Emami share price performed last year?
The Emami share price has performed in a mixed way last year. It started on a high note but dipped towards mid-2022. After this, there was a peak in prices. Then the share began to slide towards January 2023 and has fallen lower since then.
What is the trending volume of Emami shares?
The trending volume of Emami shares according to the NSE is 4,60,297 (7 April 2023).